2027 ICD-10-CM Diagnosis Code N61.20Granulomatous mastitis, unspecified breast
ICD-10-CM Codes›N00–N99›N60-N65›N61
- Billable — Valid for Submission
- Chronic Condition
N61.20 is a billable ICD-10-CM diagnosis code for granulomatous mastitis, unspecified breast. It is valid on HIPAA claims for fiscal year 2027 (October 1, 2026 through September 30, 2027) and groups to MS-DRG 600 through 601. Coders also document this condition as granulomatous mastitis. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Nonmalignant breast conditions.
Code Identity
Code Classification
Approximate SynonymsGuidance
Alternate terms and clinical phrases that map to this code.
- Granulomatous mastitis
Instructional NotesGuidance
Instructions from the official ICD-10-CM Tabular List that apply to N61.20: its own notes plus those printed at N61, block N60-N65, and Chapter 14. A note printed at a category, block or chapter applies to every code under it.
Excludes1
Not coded here: the excluded code is never reported together with this one, unless the two conditions are unrelated.
Excludes2
Not included here: the excluded condition is not part of this code, but a patient may have both, so both codes may be reported.
- certain conditions originating in the perinatal period (P04-P96)
- certain infectious and parasitic diseases (A00-B99)
- complications of pregnancy, childbirth and the puerperium (O00-O9A)
- congenital malformations, deformations and chromosomal abnormalities (Q00-Q99)
- endocrine, nutritional and metabolic diseases (E00-E88)
- injury, poisoning and certain other consequences of external causes (S00-T88)
- neoplasms (C00-D49)
- symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R94)
Source: CMS ICD-10-CM Tabular List. How to read instructional notes.
Clinical ClassificationClinical
AHRQ’s CCSR groups this code into broader clinical categories.
Clinical InformationClinical
Granulomatous Mastitis
a rare, benign, inflammatory breast disease occurring in premenopausal women shortly after a recent pregnancy. the origin is unknown but it is commonly mistaken for malignancy and sometimes associated with breast feeding and the use of oral contraceptives.
Patient EducationClinical
Breast Diseases
Breast diseases include various conditions and changes in your breast. Most women experience breast changes at some time. Your age, hormone levels, and medicines you take may cause lumps, bumps, and discharges of fluids that are not breast milk.
The full article covers:
- What are breast diseases?
- What are the symptoms of breast disease?
- How are breast diseases diagnosed?
- What are the treatments for breast disease?
Read the full article at MedlinePlus
Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.
Code History & ChangesHistory
Replacement N61.20 replaces the following previously assigned code(s):
- N61.0 - Mastitis without abscess
Questions About N61.20Overview
What is the ICD-10 code for granulomatous mastitis, unspecified breast?
The ICD-10-CM code for granulomatous mastitis, unspecified breast is N61.20 (sometimes written as N6120). It is billable on HIPAA-covered claims from October 1, 2026 through September 30, 2027.
Is N61.20 (Granulomatous mastitis) a billable code?
Yes. This is a billable ICD-10-CM code, specific enough to report granulomatous mastitis, unspecified breast on HIPAA-covered claims from October 1, 2026 through September 30, 2027.
What MS-DRG does N61.20 group to?
When granulomatous mastitis, unspecified breast is the principal diagnosis on an inpatient stay, it groups to MS-DRG 600, 601, with relative weights from 0.6014 to 0.9971 depending on complications. Higher weights mean higher Medicare reimbursement.
Can N61.20 be reported with a code from C50.A?
Not as a rule. The Excludes1 note at N61, which applies to N61.20, lists "inflammatory carcinoma of breast (C50.A-)". An Excludes1 note means the excluded code is never reported together with this one; the only exception is when the two conditions are unrelated to each other (Official Guidelines, Section I.A.12.a).